ECAM
REGN icon

East Coast Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

East Coast Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-3,401
Closed -$765K – 290
2013
Q2 		$765K Buy
+3,401
New +$792K 0.41% 68

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

East Coast Asset Management's REGN Position: Q3 2013 in Review

East Coast Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2013, closing a stake of 3,401 shares — an estimated $765K sold.

East Coast Asset Management first reported a position in REGN in Q2 2013 and held it in 1 quarter. The position peaked at $765K in Q2 2013. 414 funds tracked by Wall St. Rank hold REGN as of Q3 2013.

  • East Coast Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • East Coast Asset Management sold 3,401 Regeneron Pharmaceuticals shares in Q3 2013, an estimated $765K.
  • East Coast Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • East Coast Asset Management's Regeneron Pharmaceuticals position peaked at $765K in Q2 2013.
  • 414 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2013.

Based on East Coast Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.